EPB41L3 (Erythrocyte Membrane Protein Band 4.1 Like 3)

A member of the 4.1 family of cytoskeletal proteins involved in cell adhesion, motility, and tumor suppression.

Gene Information Card

Symbol EPB41L3
Full Name Erythrocyte Membrane Protein Band 4.1 Like 3
Gene Type protein-coding
Chromosomal Location 18p11.32
NCBI Gene ID 23136 ncbi.nlm.nih.gov/gene/23136
Ensembl ID ENSG00000134352
UniProt ID Q9Y2J2
OMIM ID 605331
HGNC ID 3382
Aliases 4.1B, DAL1, DAL-1, EPB41L3

Description

EPB41L3 encodes a member of the protein 4.1 family, which links the spectrin-actin cytoskeleton to the plasma membrane. The encoded protein, 4.1B (also known as DAL-1), is widely expressed and plays roles in cell adhesion, motility, and growth regulation. It is frequently downregulated or lost in various cancers, suggesting a tumor suppressor function.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Meningioma Loss of EPB41L3 expression correlates with tumor progression; acts as a tumor suppressor by modulating cell adhesion and proliferation. Multiple studies (e.g., Gutmann et al., 2000; NCBI GeneReviews)
Breast Cancer Reduced expression of EPB41L3 is associated with invasive phenotype; re-expression suppresses cell migration and invasion. Immunohistochemistry and functional assays (e.g., Tran et al., 1999; COSMIC)
Lung Cancer EPB41L3 promoter hypermethylation and loss of expression contribute to tumorigenesis. Methylation-specific PCR and expression analysis (e.g., Kikuchi et al., 2005; ClinVar)
Prostate Cancer Downregulation of EPB41L3 is linked to aggressive disease and metastasis. Gene expression profiling and functional studies (e.g., Wong et al., 2007; OMIM)

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Lung 8.3 Low
Breast 6.1 Low
Prostate 5.4 Low
Kidney 10.2 Medium
Cell Line Expression
Cell Line nTPM Notes
HEK 293 15.0 High expression in embryonic kidney cells
MCF7 4.2 Low expression in breast cancer cell line
A549 3.8 Low expression in lung cancer cell line
U87MG 6.5 Medium expression in glioblastoma cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1234C>T (p.Arg412*) Nonsense <0.1% Premature truncation; loss of function
c.567_568del (p.Glu190fs) Frameshift <0.1% Frameshift leading to nonsense-mediated decay
c.890G>A (p.Arg297Gln) Missense <0.1% Unknown significance; predicted benign by in silico tools
Mutation functional classification

Loss of Function (LOF)

Nonsense and frameshift mutations (e.g., p.Arg412*, p.Glu190fs) lead to truncated or absent protein, consistent with tumor suppressor loss.

Gain of Function (GOF)

No gain-of-function mutations reported for EPB41L3.

Dominant Negative (DN)

No dominant-negative mutations described for EPB41L3.

Pathways

Cytoskeleton remodeling (REACT_18266)
Cell adhesion and migration (WP455)

Protein Summary

The EPB41L3 protein (4.1B) is a 108 kDa member of the protein 4.1 family. It contains a conserved FERM domain that mediates binding to membrane proteins and the spectrin-actin cytoskeleton. 4.1B is involved in maintaining cell shape, adhesion, and motility. Loss of 4.1B expression is observed in multiple cancers, and its re-expression suppresses tumor cell growth and invasion, supporting its role as a tumor suppressor.

Related Products

Product name Cat.No. Species Gene ID
EPB41L3 Knockout HEK293 Cell Line EDJ-KQ3882 Human 23136 Details Get a Quote
EPB41L3 Knockout A-549 Cell Line EDJ-KQ26093 Human 23136 Details Get a Quote
EPB41L3 Knockout HeLa Cell Line EDJ-KQ55692 Human 23136 Details Get a Quote
EPB41L3 Knockout HCT 116 Cell Line EDJ-KQ72635 Human 23136 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: